Boryung wins EU-GMP certification for oral drug plant in South Korea
AI Summary- Boryung secured EU-GMP certification for its oral solid dosage facility in Yesan.
- 870 million tablets is the Yesan campus’s annual oral solid dosage capacity.
- Boryung’s injectable anticancer facility at the same plant received approval in 2023.